Baird Downgrades BioMarin Pharmaceutical To Neutral

By: via Benzinga
Baird downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Outperform to Neutral. BioMarin Pharmaceutical shares have gained ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.